While Insulet Corporation has overperformed by 1.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PODD fell by -42.79%, with highs and lows ranging from $335.91 to $125.82, whereas the simple moving average fell by -8.12% in the last 200 days.
On December 21, 2023, Robert W. Baird Upgraded Insulet Corporation (NASDAQ: PODD) to Outperform. A report published by Morgan Stanley on December 04, 2023, Upgraded its rating to ‘Overweight’ for PODD. Jefferies also Upgraded PODD shares as ‘Buy’, setting a target price of $240 on the company’s shares in a report dated October 02, 2023. Citigroup August 21, 2023d the rating to Buy on August 21, 2023, and set its price target from $273 to $265. Robert W. Baird August 21, 2023d its ‘Outperform’ rating to ‘Neutral’ for PODD, as published in its report on August 21, 2023. Morgan Stanley’s report from May 30, 2023 suggests a price prediction of $343 for PODD shares, giving the stock a ‘Equal-Weight’ rating. Wolfe Research also rated the stock as ‘Peer Perform’.
Analysis of Insulet Corporation (PODD)
Further, the quarter-over-quarter increase in sales is 37.90%, showing a positive trend in the upcoming months.
Insulet Corporation’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of 34.12% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.58, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and PODD has an average volume of 872.12K. On a monthly basis, the volatility of the stock is set at 3.53%, whereas on a weekly basis, it is put at 3.51%, with a gain of 10.05% over the past seven days. Furthermore, long-term investors anticipate a median target price of $236.02, showing growth from the present price of $179.65, which can serve as yet another indication of whether PODD is worth investing in or should be passed over.
How Do You Analyze Insulet Corporation Shares?
Medical Devices giant Insulet Corporation (PODD) is based in the USA and is one of the largest companies in the market. When comparing Insulet Corporation shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 61.69, there is a growth in quarterly earnings of 509.02%.
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.78%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 102.42% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PODD shares are owned by institutional investors to the tune of 102.42% at present.
